HB 1168 makes it a felony to knowingly deliver or possess abortion-inducing drugs (like misoprostol or methotrexate) with the intent of causing an abortion, punishable by up to $100,000 in fines or 10 years in prison. It directly affects individuals who provide such drugs for non-exceptional purposes, including off-label use for abortion. Key exceptions include pharmacists, manufacturers, and distributors acting within lawful medical practices, as well as preventive contraception used as directed by manufacturers. The law does not restrict treatment for ectopic pregnancies, miscarriages, or medical uses of drugs like chemotherapy.
HB 3143 extends Oklahoma's moratorium on new medical marijuana business licenses (dispensaries, processors, growers) from August 1, 2026, to August 1, 2028. It requires existing license holders to get written approval from the Oklahoma Medical Marijuana Authority before transferring ownership, including submitting documentation to the Oklahoma State Bureau of Narcotics. Transfers must follow a 15-business-day timeline for license and registration changes, and applicants cannot submit transfer requests if disciplinary actions are pending. The bill also mandates that businesses provide a full inventory of all medical marijuana products during ownership changes and prohibits transfers without approval, with a 30-day window for pending applications to comply with new rules.
SB 1645 establishes new rules for auditing long-term care providers (like nursing homes and Medicaid home-care agencies) under Oklahoma's Medicaid program. It requires the Oklahoma Health Care Authority to give providers 1 week's notice before audits, limits audits to 50 claims or 0.25% of annual claims, and prohibits holding providers liable for simple clerical errors (like typos) as fraud. Providers must be allowed 60 days to correct claims after an audit, and recoupments (recovery of overpaid funds) can only apply to corrected claims, not original billing errors. The bill also creates a two-step appeals process, allowing providers to challenge audit results through the Authority and then to an administrative law judge.
SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
SB 1134 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2026 fiscal year. The bill directly provides funding for the Authority to carry out its legal duties. It declares an emergency to allow immediate implementation upon passage. This is a procedural appropriations measure with no policy changes beyond the specified funding amount.
SB 1142 allocates $100,000 from unallocated state funds to Oklahoma's Department of Mental Health and Substance Abuse Services for the 2025-2026 fiscal year. The funding is intended to support the department's existing duties, including providing mental health and substance abuse services to Oklahomans. The bill declares an emergency to allow immediate implementation upon approval, bypassing standard legislative timelines. This is a procedural funding measure, not a policy change, and remains pending before the Appropriations Committee.
SB 1290 allocates $3 million from Oklahoma's General Revenue Fund to maintain the state's 2-1-1 hotline for the 2027 fiscal year. The funding ensures the hotline continues providing direct support for basic needs like food, shelter, clothing, transportation, and medical assistance. This appropriation directly affects Oklahomans who rely on the 2-1-1 service for immediate help. The bill takes effect July 1, 2026.
HB 3329 extends the expiration date of Oklahoma's Long-Term Care Facility Advisory Board from July 1, 2025, to July 1, 2027. The bill modifies Oklahoma Statutes Section 1-1923 to continue the board's operation, which advises the State Commissioner of Health on long-term care services. The advisory board, composed of 13 members including healthcare professionals, facility operators, and public representatives, provides recommendations on care standards for nursing homes, residential care facilities, and adult day care centers. The bill takes effect July 1, 2026, as an emergency measure.
SB 1369 allocates $5.7 million from Oklahoma's general state funds to sustain and expand the state's 9-8-8 suicide and crisis hotline operations for the 2026-2027 fiscal year. This funding directly supports Oklahomans in mental health crises by ensuring access to the 9-8-8 hotline service. The bill provides specific funding to maintain current operations while increasing capacity for crisis response. It becomes effective July 1, 2026, and declares an emergency due to the urgent need for mental health support.
HB 4457 prohibits pharmacy benefits managers (PBMs) from owning or controlling pharmacy licenses in Oklahoma. The State Board of Pharmacy must revoke licenses of violators after November 2026, though it may issue temporary licenses for rare, orphan, or limited-distribution drugs until September 2028. Pharmacies must notify patients of service changes by January 2027, and the Board must provide lists of compliant pharmacies. This law prevents conflicts of interest by restricting PBMs from owning pharmacies.
